Caruso JA, Wang X, Murrow LM, Rodriguez CI, et al. Loss of PPARgamma activity characterizes early protumorigenic stromal reprogramming and dictates the therapeutic window of opportunity. Proc Natl Acad Sci U S A 2023;120:e2303774120.
PMID: 37816052